Literature DB >> 10469919

A new method to evaluate plume characteristics of hydrofluoroalkane and chlorofluorocarbon metered dose inhalers.

B J Gabrio1, S W Stein, D J Velasquez.   

Abstract

Two concerns raised when comparing metered dose inhalers (MDIs) to other inhalation devices are their relatively high throat deposition and the 'cold-Freon' effect seen in a small number of patients. The cold-Freon effect is presumed to be a result of the cold, forceful MDI plume impacting on the back of a patient's throat. This in vitro study uses a new plume characterization method to determine the spray force and plume temperature of various MDIs. Spray force measurements were made for 28 marketed products consisting of bronchodilators, steroids, press-and-breathe, breath-actuated and nasal inhalers. Results show that chlorofluorocarbon (CFC)-containing MDIs produce extremely forceful and cold plumes. Several hydrofluoralkane (HFA)-containing MDIs produced much softer and warmer plumes, but two HFA products had spray forces similar to the CFC products. Although the type of propellant used can affect spray force, actuator orifice diameter is the most important factor. Data obtained from marketed products and experimental inhalers show that MDIs that have a low spray force also have low throat deposition.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10469919     DOI: 10.1016/s0378-5173(99)00133-7

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  10 in total

1.  Insights into Spray Development from Metered-Dose Inhalers Through Quantitative X-ray Radiography.

Authors:  Nicholas Mason-Smith; Daniel J Duke; Alan L Kastengren; Peter J Stewart; Daniela Traini; Paul M Young; Yang Chen; David A Lewis; Julio Soria; Daniel Edgington-Mitchell; Damon Honnery
Journal:  Pharm Res       Date:  2016-02-17       Impact factor: 4.200

Review 2.  In vitro and in vivo aspects of cascade impactor tests and inhaler performance: a review.

Authors:  Jolyon Mitchell; Steve Newman; Hak-Kim Chan
Journal:  AAPS PharmSciTech       Date:  2007-12-21       Impact factor: 3.246

Review 3.  Advances in metered dose inhaler technology: hardware development.

Authors:  Stephen W Stein; Poonam Sheth; P David Hodson; Paul B Myrdal
Journal:  AAPS PharmSciTech       Date:  2013-12-20       Impact factor: 3.246

4.  Effect of Inhalation Flow Rate on Mass-Based Plume Geometry of Commercially Available Suspension pMDIs.

Authors:  Daniel F Moraga-Espinoza; Eli Eshaghian; Albert Shaver; Hugh D C Smyth
Journal:  AAPS J       Date:  2018-07-12       Impact factor: 4.009

5.  Inhalation devices and patient interface: human factors.

Authors:  Stefan Leiner; David Parkins; Orest Lastow
Journal:  AAPS J       Date:  2015-01-16       Impact factor: 4.009

Review 6.  Pharmacokinetic and pharmacodynamic properties of inhaled beclometasone dipropionate delivered via hydrofluoroalkane-containing devices.

Authors:  Eric Derom; Romain A Pauwels
Journal:  Clin Pharmacokinet       Date:  2005       Impact factor: 6.447

7.  The ELLIPTA® Dry Powder Inhaler: Design, Functionality, In Vitro Dosing Performance and Critical Task Compliance by Patients and Caregivers.

Authors:  Andrew C Grant; Richard Walker; Melanie Hamilton; Karl Garrill
Journal:  J Aerosol Med Pulm Drug Deliv       Date:  2015-09-15       Impact factor: 2.849

8.  From inhaler to lung: clinical implications of the formulations of ciclesonide and other inhaled corticosteroids.

Authors:  Ruediger Nave; Helgert Mueller
Journal:  Int J Gen Med       Date:  2013-03-07

9.  The challenge of delivering therapeutic aerosols to asthma patients.

Authors:  Federico Lavorini
Journal:  ISRN Allergy       Date:  2013-08-05

10.  Tuning aerosol particle size distribution of metered dose inhalers using cosolvents and surfactants.

Authors:  Imran Y Saleem; Hugh D C Smyth
Journal:  Biomed Res Int       Date:  2013-07-24       Impact factor: 3.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.